Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
VRL.BOthis companyVasundhara Rasayans Limited	₹136.60	6.13×	0.87×	0.99×	4×	96.8%	57.7%	15.0%	16.2%	14.2%	9.2%	-5.3%	0.04×	-0.08×	13.31×	6.87×	1.8%	4	—	2	B-
ANG.BOANG Lifesciences India Limited	₹36.93	-2.19×	0.46×	0.26×	141.24×	-50.6%	10.2%	-6.1%	-11.9%	-21.0%	-3.6%	14.0%	1.5×	106.97×	-0.71×	0.97×	0.0%	3	0.43	1	C-
BACPHAR.BOBacil Pharma Limited	₹16.82	43×	2.7×	0×	-270.7×	-93.7%	0.0%	0.0%	0.0%	6.3%	-1.0%	1.1%	0×	2.32×	0×	0.68×	0.0%	2	2.81	3	B-
BALAXI.NSBalaxi Pharmaceuticals Limited	₹22.66	60.27×	0.34×	0.31×	17.26×	-101.9%	41.7%	1.9%	0.5%	0.6%	0.4%	-52.9%	0.23×	5.79×	1.36×	4.51×	0.0%	5	2.08	1	D+
CRSTCHM.BOCrestchem Limited	₹100.20	8.61×	2.36×	0.79×	5.99×	406.9%	17.8%	10.5%	9.2%	27.4%	22.5%	18.1%	0×	-0.11×	314×	0.9×	0.7%	4	—	3	B
MEDICAPQ.BOMedi-Caps Limited	₹21.07	-9.51×	0.26×	2.32×	-3.02×	-58.8%	-37.2%	-90.1%	-24.4%	-2.7%	-9.9%	-27.0%	0×	0.05×	-862.95×	17.34×	0.0%	2	—	2	C
Peer median	—	8.61×	0.46×	0.31×	5.99×	-58.8%	10.2%	0.0%	0.0%	0.6%	-1.0%	1.1%	0×	2.32×	0×	0.97×	0.0%	3	2.08	2	—